PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BSX vs. GLDM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BSX and GLDM is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

BSX vs. GLDM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and SPDR Gold MiniShares Trust (GLDM). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
26.05%
12.57%
BSX
GLDM

Key characteristics

Sharpe Ratio

BSX:

3.57

GLDM:

2.29

Sortino Ratio

BSX:

4.89

GLDM:

2.97

Omega Ratio

BSX:

1.65

GLDM:

1.40

Calmar Ratio

BSX:

8.63

GLDM:

4.27

Martin Ratio

BSX:

35.79

GLDM:

11.64

Ulcer Index

BSX:

1.73%

GLDM:

2.97%

Daily Std Dev

BSX:

17.31%

GLDM:

15.06%

Max Drawdown

BSX:

-89.15%

GLDM:

-21.63%

Current Drawdown

BSX:

0.00%

GLDM:

-3.08%

Returns By Period

In the year-to-date period, BSX achieves a 10.46% return, which is significantly higher than GLDM's 2.96% return.


BSX

YTD

10.46%

1M

10.92%

6M

26.05%

1Y

61.90%

5Y*

17.58%

10Y*

20.93%

GLDM

YTD

2.96%

1M

2.98%

6M

12.58%

1Y

33.06%

5Y*

11.54%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BSX vs. GLDM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX
The Risk-Adjusted Performance Rank of BSX is 9999
Overall Rank
The Sharpe Ratio Rank of BSX is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 9898
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9797
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9999
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9999
Martin Ratio Rank

GLDM
The Risk-Adjusted Performance Rank of GLDM is 8383
Overall Rank
The Sharpe Ratio Rank of GLDM is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of GLDM is 8181
Sortino Ratio Rank
The Omega Ratio Rank of GLDM is 8181
Omega Ratio Rank
The Calmar Ratio Rank of GLDM is 9191
Calmar Ratio Rank
The Martin Ratio Rank of GLDM is 7878
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BSX vs. GLDM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and SPDR Gold MiniShares Trust (GLDM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BSX, currently valued at 3.57, compared to the broader market-2.000.002.004.003.572.29
The chart of Sortino ratio for BSX, currently valued at 4.89, compared to the broader market-4.00-2.000.002.004.004.892.97
The chart of Omega ratio for BSX, currently valued at 1.65, compared to the broader market0.501.001.502.001.651.40
The chart of Calmar ratio for BSX, currently valued at 8.63, compared to the broader market0.002.004.006.008.634.27
The chart of Martin ratio for BSX, currently valued at 35.79, compared to the broader market-10.000.0010.0020.0030.0035.7911.64
BSX
GLDM

The current BSX Sharpe Ratio is 3.57, which is higher than the GLDM Sharpe Ratio of 2.29. The chart below compares the historical Sharpe Ratios of BSX and GLDM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
3.57
2.29
BSX
GLDM

Dividends

BSX vs. GLDM - Dividend Comparison

Neither BSX nor GLDM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BSX vs. GLDM - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than GLDM's maximum drawdown of -21.63%. Use the drawdown chart below to compare losses from any high point for BSX and GLDM. For additional features, visit the drawdowns tool.


-8.00%-6.00%-4.00%-2.00%0.00%AugustSeptemberOctoberNovemberDecember20250
-3.08%
BSX
GLDM

Volatility

BSX vs. GLDM - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 6.18% compared to SPDR Gold MiniShares Trust (GLDM) at 4.29%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than GLDM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%AugustSeptemberOctoberNovemberDecember2025
6.18%
4.29%
BSX
GLDM
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab